AdAlta Limited (1AD.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 12:49PM AEST
| Previous close | 0.0540 |
| Open | 0.0550 |
| Bid | 0.0550 x 25215400 |
| Ask | 0.0590 x 5549800 |
| Day's range | 0.0550 - 0.0560 |
| 52-week range | 0.0440 - 0.1500 |
| Volume | |
| Avg. volume | 224,919 |
| Market cap | 17.28M |
| Beta (5Y monthly) | 0.85 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0190 |
| Earnings date | 25 Aug 2022 - 29 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
ASX Announcement: AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics
AdAlta Limited (ASX:1AD) and Carina Biotech Pty Ltd have entered a collaboration agreement to develop next-generation i-body enabled CAR-T cells, with the potential to bring CAR-T cell therapy to treat a far greater range of cancers than the small number of blood cancers that has been achieved today.
© 2022 Yahoo. All rights reserved.
